Adam A. Capoferri

Johns Hopkins University — United States

Immunology and Microbiology · Life Sciences

18h-index3.4kcitations47works3.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(37), HIV/AIDS drug development and treatment(26), HIV/AIDS Research and Interventions(13), Immune Cell Function and Interaction(11), Cytomegalovirus and herpesvirus research(8)

Publications47 total

Estimating HIV-1 Viremic Time From Reservoir Sequence Diversity With Uncertainty Quantification
The Journal of Infectious Diseases·2026
In vivo detection of antisense HIV-1 transcripts in untreated and ART-treated individuals
Life Science Alliance·2025· 2 citedOpen Access
Differential HIV-1 Proviral Defects in Children vs. Adults on Antiretroviral Therapy
Viruses·2025Open Access
Differential HIV-1 Proviral Defects in Children vs. Adults on Antiretroviral Therapy
2025· 1 citedOpen Access
Association between HIV-1 Nef-mediated MHC-I downregulation and the maintenance of the replication-competent latent viral reservoir in individuals with virally suppressed HIV-1 in Uganda: an exploratory cohort study
The Lancet Microbe·2025· 5 citedOpen Access
Divergent populations of HIV-infected naive and memory CD4+ T cell clones in children on antiretroviral therapy
Journal of Clinical Investigation·2025· 5 citedOpen Access
<i>In vivo</i> detection of HIV-1 antisense transcripts in untreated and ART-treated individuals
2024· 2 citedOpen Access
HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNA
Proceedings of the National Academy of Sciences·2024· 7 citedOpen Access
HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNA
2024· 2 citedOpen Access
Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimen
EBioMedicine·2024· 6 citedOpen Access
HIV Expression in Infected T Cell Clones
Viruses·2024· 6 citedOpen Access
HIV Expression in Infected T Cell Clones
Preprints.org·2023· 1 citedOpen Access
Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimen
2023Open Access
PP 7.7 – 00055 Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to a Dolutegravir-based antiretroviral regiment
Journal of Virus Eradication·2022Open Access
A Pre-Vaccination Baseline of SARS-CoV-2 Genetic Surveillance and Diversity in the United States
Viruses·2022· 1 citedOpen Access
2020 SARS-CoV-2 diversification in the United States: Establishing a pre-vaccination baseline
2021· 3 citedOpen Access
Assessment of West Nile Virus Lineage 2 Dynamics in Greece and Future Implications
Vector-Borne and Zoonotic Diseases·2021
Sars-cov-2 genetic diversity increased at least 3-fold in the us in 2020
Topics in antiviral medicine·2021
Low genetic diversity may be an Achilles heel of SARS-CoV-2
Proceedings of the National Academy of Sciences·2020· 113 citedOpen Access
Haemopoietic cell transplantation in patients living with HIV
The Lancet HIV·2020· 25 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Robert F. Siliciano(16), Mary F. Kearney(16), Janet D. Siliciano(11), Andrew D. Redd(11), Jason W. Rausch(10), Christine M. Durand(9), John M. Coffin(9), Steven J. Reynolds(9), Jun Lai(8), Brian T. Luke(8), Richard F. Ambinder(8), Thomas C. Quinn(8), Jessica L. Prodger(8), Steven G. Deeks(7), Michael J. Bale(7), Wei Shao(7), Briana Lynch(7), Katherine M. Bruner(6), Rebecca Hoh(6), Nina N. Hosmane(6)